What is the difference between oral Wegovy and compounded oral semaglutide
When you eat, your intestines release GLP-1, which signals your pancreas to produce insulin, slows how quickly food leaves your stomach, and communicates with your brain to reduce appetite
Factors such as diet, exercise habits, genetics, overall health, and adherence to treatment plans can influence individual results
Microdosing and alternative dosing of GLP-1s has not been studied nor is FDA approved
Public health initiatives, favorable reimbursement schemes, and widespread clinical research support market potential
Irelands current policy approach to obesity Irelands approach to obesity includes: Public health campaigns Nutritional labelling initiatives Sugar tax implementation School-based health interventions National obesity policy frameworks The HSEs strategic plans recognise obesity as a chronic disease requiring long-term management